Related Experiment Video
Updated: Feb 16, 2026

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
Krüppel-like factor 2 suppresses human gastric tumorigenesis through inhibiting PTEN/AKT signaling
Chunmei Wang1,2,3, Liang Li1, Qiuhui Duan1
1East China Normal University and Shanghai Fengxian District Central Hospital Joint Center for Translational Medicine, Shanghai 200241, China.
Abstract:
Krüppel-like factors (KLFs) are a large family of DNA-binding transcriptional regulators that affect basic cellular processes such as growth, survival, migration and differentiation and serve a complicated function in cancers. KLF2, one member of the KLF family, is dysregulated in many tumors. However, the specific role of KLF2 in human gastric tumorigenesis is unknown. Here we show that the expression of KLF2 protein was lower in gastric tumors when compared with adjacent normal tissue. Moreover, downregulated KLF2 expression in primary gastric tumor was closely correlated with patients' survival. Various cell experiments showed that ectopic KLF2 expression suppressed the proliferation, migration and invasion of gastric cancer cells. Moreover, KLF2 overexpression remarkably enhanced cell apoptosis and induced cell cycle arrest. Impaired expression of KLF2 markedly promoted cell growth in vitro and significantly expanded tumor size in vivo. Mechanically, the mRNA and protein level of PTEN was reduced in KLF2 deficient cells and xenograft tumors, suggesting that PTEN/AKT signaling was involved in the gastric tumor inhibitory effect of KLF2. Administration of AKT inhibitor AZD5363 or Insulin-like growth factor-1 (IGF-1) in KLF2 knockdown or ectopic expression cell lines, respectively, substantially reversed the proliferation phenotype. Collectively, our findings provide clinical evidence and a potential mechanism supporting that KLF2 suppresses human gastric tumorigenesis through inhibiting the PTEN/AKT axis.
Insights
Krüppel-like factor 2 (KLF2) is downregulated in gastric tumors, suppressing cancer growth and progression. KLF2 inhibits gastric tumorigenesis by regulating the PTEN/AKT signaling pathway, offering a potential therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Krüppel-like factors (KLFs) are transcriptional regulators involved in cellular processes and cancer.
- KLF2 is frequently dysregulated in various tumors, but its role in gastric cancer is unclear.
Purpose of the Study:
- To investigate the role of KLF2 in human gastric tumorigenesis.
- To elucidate the underlying molecular mechanisms of KLF2's function in gastric cancer.
Main Methods:
- Analysis of KLF2 protein expression in gastric tumors and adjacent normal tissues.
- In vitro cell experiments (proliferation, migration, invasion, apoptosis, cell cycle) with KLF2 manipulation.
- In vivo xenograft tumor models to assess KLF2's effect on tumor growth.
- Investigation of PTEN/AKT signaling pathway involvement and validation using specific inhibitors (AZD5363) and growth factors (IGF-1).
Main Results:
- KLF2 protein expression was significantly lower in gastric tumors compared to normal tissues.
- Downregulated KLF2 correlated with poorer patient survival.
- Ectopic KLF2 expression suppressed gastric cancer cell proliferation, migration, and invasion, while enhancing apoptosis and inducing cell cycle arrest.
- KLF2 deficiency promoted tumor growth in vitro and in vivo.
- KLF2 regulated PTEN expression, impacting the PTEN/AKT signaling pathway.
Conclusions:
- KLF2 acts as a tumor suppressor in human gastric cancer.
- KLF2 suppresses gastric tumorigenesis by inhibiting the PTEN/AKT signaling axis.
- KLF2 represents a potential therapeutic target for gastric cancer treatment.
More Related Videos
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
10:28Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
Related Concept Videos
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
TGF - β Signaling Pathway